HEADER HYDROLASE 25-APR-22 7ZOC TITLE CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE H FROM TITLE 2 CLOSTRIDIUM HISTOLYTICUM IN COMPLEX WITH N-ARYL-2- TITLE 3 ALKYLMERCAPTOACETAMIDE-BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: COLLAGENASE COLH; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CLASS II COLLAGENASE,GELATINASE COLH,MICROBIAL COLLAGENASE; COMPND 5 EC: 3.4.24.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HATHEWAYA HISTOLYTICA; SOURCE 3 ORGANISM_TAXID: 1498; SOURCE 4 GENE: COLH; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COLLAGENASE, INHIBITOR, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHOENAUER,H.BRANDSTETTER REVDAT 2 07-FEB-24 7ZOC 1 REMARK REVDAT 1 10-MAY-23 7ZOC 0 JRNL AUTH E.SCHOENAUER,H.BRANDSTETTER JRNL TITL N-ARYL-2-ISO-BUTYLMERCAPTOACETAMIDES: THE DISCOVERY OF JRNL TITL 2 HIGHLY POTENT AND SELECTIVE INHIBITORS OF P. AERUGINOSA JRNL TITL 3 VIRULENCE FACTOR LASB AND C. HISTOLYTICUM VIRULENCE FACTOR JRNL TITL 4 COLH JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19RC5_4047 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 34321 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1759 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.6000 - 4.4900 0.99 2656 155 0.1654 0.1979 REMARK 3 2 4.4900 - 3.5600 1.00 2546 146 0.1579 0.2054 REMARK 3 3 3.5600 - 3.1100 0.99 2520 142 0.1941 0.2155 REMARK 3 4 3.1100 - 2.8300 0.99 2505 135 0.2134 0.2669 REMARK 3 5 2.8300 - 2.6300 1.00 2514 146 0.2136 0.2778 REMARK 3 6 2.6300 - 2.4700 1.00 2484 124 0.2144 0.2428 REMARK 3 7 2.4700 - 2.3500 1.00 2484 125 0.2005 0.2530 REMARK 3 8 2.3500 - 2.2500 1.00 2530 121 0.2036 0.2681 REMARK 3 9 2.2500 - 2.1600 0.99 2443 153 0.2259 0.2942 REMARK 3 10 2.1600 - 2.0800 1.00 2476 136 0.2357 0.2916 REMARK 3 11 2.0800 - 2.0200 1.00 2460 125 0.2496 0.3174 REMARK 3 12 2.0200 - 1.9600 1.00 2492 123 0.2881 0.3641 REMARK 3 13 1.9600 - 1.9100 0.99 2452 128 0.3567 0.4221 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3168 REMARK 3 ANGLE : 1.025 4293 REMARK 3 CHIRALITY : 0.063 442 REMARK 3 PLANARITY : 0.009 566 REMARK 3 DIHEDRAL : 5.643 442 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZOC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292122601. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97242 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34338 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 43.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5O7E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES/MOPS PH 7.1, 1,6-HEXANEDIOL, 1 REMARK 280 -BUTANOL, 1,2-PROPANEDIOL, 2-PROPANOL, 1,4-BUTANEDIOL, 1,3- REMARK 280 PROPANEDIOL, MPD, PEG 1000, PEG 3350, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.71250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.47700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.99050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.47700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.71250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.99050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 90 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 309 REMARK 465 GLY A 310 REMARK 465 SER A 311 REMARK 465 SER A 312 REMARK 465 HIS A 313 REMARK 465 HIS A 314 REMARK 465 HIS A 315 REMARK 465 HIS A 316 REMARK 465 HIS A 317 REMARK 465 HIS A 318 REMARK 465 SER A 319 REMARK 465 SER A 320 REMARK 465 GLY A 321 REMARK 465 GLU A 322 REMARK 465 ASN A 323 REMARK 465 LEU A 324 REMARK 465 TYR A 325 REMARK 465 PHE A 326 REMARK 465 GLN A 327 REMARK 465 GLY A 328 REMARK 465 GLY A 329 REMARK 465 THR A 330 REMARK 465 LEU A 331 REMARK 465 ASP A 332 REMARK 465 LYS A 333 REMARK 465 PHE A 334 REMARK 465 LYS A 335 REMARK 465 LYS A 336 REMARK 465 GLU A 337 REMARK 465 GLY A 338 REMARK 465 LYS A 339 REMARK 465 GLU A 340 REMARK 465 LYS A 341 REMARK 465 GLU A 720 REMARK 465 GLY A 721 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 GLU A 393 CG CD OE1 OE2 REMARK 470 LEU A 413 CG CD1 CD2 REMARK 470 VAL A 416 CG1 CG2 REMARK 470 LEU A 417 CG CD1 CD2 REMARK 470 TYR A 418 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 421 CG OD1 OD2 REMARK 470 ASN A 423 CG OD1 ND2 REMARK 470 GLN A 443 CG CD OE1 NE2 REMARK 470 LYS A 475 CG CD CE NZ REMARK 470 GLU A 600 CG CD OE1 OE2 REMARK 470 ARG A 614 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 700 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 388 30.72 -144.36 REMARK 500 THR A 437 -162.70 -165.26 REMARK 500 ASP A 552 53.66 -161.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 802 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 430 OE2 REMARK 620 2 GLY A 463 O 79.2 REMARK 620 3 VAL A 467 O 162.7 91.9 REMARK 620 4 GLY A 469 O 88.6 160.2 103.6 REMARK 620 5 HOH A 989 O 79.8 104.1 88.2 88.7 REMARK 620 6 HOH A1006 O 100.2 76.6 91.9 90.5 179.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 801 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 455 NE2 REMARK 620 2 HIS A 459 NE2 104.4 REMARK 620 3 GLU A 487 OE1 96.4 101.8 REMARK 620 4 T8E A 803 S03 108.2 124.7 117.2 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5O7E RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH N-ARYL MERCAPTOACETAMIDE- REMARK 900 BASED INHIBITOR DBREF 7ZOC A 331 721 UNP Q46085 COLH_HATHI 331 721 SEQADV 7ZOC MET A 309 UNP Q46085 INITIATING METHIONINE SEQADV 7ZOC GLY A 310 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC SER A 311 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC SER A 312 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 313 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 314 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 315 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 316 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 317 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 318 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC SER A 319 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC SER A 320 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC GLY A 321 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC GLU A 322 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC ASN A 323 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC LEU A 324 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC TYR A 325 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC PHE A 326 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC GLN A 327 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC GLY A 328 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC GLY A 329 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC THR A 330 UNP Q46085 EXPRESSION TAG SEQADV 7ZOC HIS A 582 UNP Q46085 TYR 582 CONFLICT SEQADV 7ZOC VAL A 659 UNP Q46085 ALA 659 CONFLICT SEQADV 7ZOC LYS A 706 UNP Q46085 ARG 706 CONFLICT SEQRES 1 A 413 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 413 GLU ASN LEU TYR PHE GLN GLY GLY THR LEU ASP LYS PHE SEQRES 3 A 413 LYS LYS GLU GLY LYS GLU LYS TYR CYS PRO LYS THR TYR SEQRES 4 A 413 THR PHE ASP ASP GLY LYS VAL ILE ILE LYS ALA GLY ALA SEQRES 5 A 413 ARG VAL GLU GLU GLU LYS VAL LYS ARG LEU TYR TRP ALA SEQRES 6 A 413 SER LYS GLU VAL ASN SER GLN PHE PHE ARG VAL TYR GLY SEQRES 7 A 413 ILE ASP LYS PRO LEU GLU GLU GLY ASN PRO ASP ASP ILE SEQRES 8 A 413 LEU THR MET VAL ILE TYR ASN SER PRO GLU GLU TYR LYS SEQRES 9 A 413 LEU ASN SER VAL LEU TYR GLY TYR ASP THR ASN ASN GLY SEQRES 10 A 413 GLY MET TYR ILE GLU PRO GLU GLY THR PHE PHE THR TYR SEQRES 11 A 413 GLU ARG GLU ALA GLN GLU SER THR TYR THR LEU GLU GLU SEQRES 12 A 413 LEU PHE ARG HIS GLU TYR THR HIS TYR LEU GLN GLY ARG SEQRES 13 A 413 TYR ALA VAL PRO GLY GLN TRP GLY ARG THR LYS LEU TYR SEQRES 14 A 413 ASP ASN ASP ARG LEU THR TRP TYR GLU GLU GLY GLY ALA SEQRES 15 A 413 GLU LEU PHE ALA GLY SER THR ARG THR SER GLY ILE LEU SEQRES 16 A 413 PRO ARG LYS SER ILE VAL SER ASN ILE HIS ASN THR THR SEQRES 17 A 413 ARG ASN ASN ARG TYR LYS LEU SER ASP THR VAL HIS SER SEQRES 18 A 413 LYS TYR GLY ALA SER PHE GLU PHE TYR ASN TYR ALA CYS SEQRES 19 A 413 MET PHE MET ASP TYR MET TYR ASN LYS ASP MET GLY ILE SEQRES 20 A 413 LEU ASN LYS LEU ASN ASP LEU ALA LYS ASN ASN ASP VAL SEQRES 21 A 413 ASP GLY TYR ASP ASN TYR ILE ARG ASP LEU SER SER ASN SEQRES 22 A 413 HIS ALA LEU ASN ASP LYS TYR GLN ASP HIS MET GLN GLU SEQRES 23 A 413 ARG ILE ASP ASN TYR GLU ASN LEU THR VAL PRO PHE VAL SEQRES 24 A 413 ALA ASP ASP TYR LEU VAL ARG HIS ALA TYR LYS ASN PRO SEQRES 25 A 413 ASN GLU ILE TYR SER GLU ILE SER GLU VAL ALA LYS LEU SEQRES 26 A 413 LYS ASP ALA LYS SER GLU VAL LYS LYS SER GLN TYR PHE SEQRES 27 A 413 SER THR PHE THR LEU ARG GLY SER TYR THR GLY GLY VAL SEQRES 28 A 413 SER LYS GLY LYS LEU GLU ASP GLN LYS ALA MET ASN LYS SEQRES 29 A 413 PHE ILE ASP ASP SER LEU LYS LYS LEU ASP THR TYR SER SEQRES 30 A 413 TRP SER GLY TYR LYS THR LEU THR ALA TYR PHE THR ASN SEQRES 31 A 413 TYR LYS VAL ASP SER SER ASN LYS VAL THR TYR ASP VAL SEQRES 32 A 413 VAL PHE HIS GLY TYR LEU PRO ASN GLU GLY HET ZN A 801 1 HET CA A 802 1 HET T8E A 803 15 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM T8E ~{N}-(4-ETHANOYLPHENYL)-2-SULFANYL-PROPANAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 CA CA 2+ FORMUL 4 T8E C11 H13 N O2 S FORMUL 5 HOH *279(H2 O) HELIX 1 AA1 GLU A 363 GLY A 386 1 24 HELIX 2 AA2 ASN A 395 ILE A 399 5 5 HELIX 3 AA3 SER A 407 GLY A 419 1 13 HELIX 4 AA4 GLU A 430 GLU A 432 5 3 HELIX 5 AA5 THR A 448 ALA A 466 1 19 HELIX 6 AA6 TYR A 477 ARG A 481 5 5 HELIX 7 AA7 LEU A 482 ALA A 494 1 13 HELIX 8 AA8 ARG A 505 HIS A 513 1 9 HELIX 9 AA9 THR A 516 ARG A 520 5 5 HELIX 10 AB1 LYS A 522 VAL A 527 1 6 HELIX 11 AB2 GLU A 536 ASP A 552 1 17 HELIX 12 AB3 ASP A 552 ASN A 565 1 14 HELIX 13 AB4 ASP A 567 SER A 580 1 14 HELIX 14 AB5 ASN A 581 ASN A 598 1 18 HELIX 15 AB6 TYR A 599 LEU A 602 5 4 HELIX 16 AB7 ALA A 608 VAL A 613 5 6 HELIX 17 AB8 ASN A 619 LYS A 632 1 14 HELIX 18 AB9 GLY A 662 THR A 683 1 22 HELIX 19 AC1 TRP A 686 LEU A 692 5 7 SHEET 1 AA1 5 LYS A 345 PHE A 349 0 SHEET 2 AA1 5 VAL A 354 ALA A 358 -1 O ILE A 356 N TYR A 347 SHEET 3 AA1 5 LEU A 400 TYR A 405 1 O MET A 402 N LYS A 357 SHEET 4 AA1 5 THR A 434 TYR A 438 1 O THR A 437 N TYR A 405 SHEET 5 AA1 5 GLY A 426 ILE A 429 -1 N ILE A 429 O THR A 434 SHEET 1 AA2 4 LYS A 634 LYS A 642 0 SHEET 2 AA2 4 SER A 647 VAL A 659 -1 O SER A 654 N LYS A 634 SHEET 3 AA2 4 LYS A 706 LEU A 717 -1 O VAL A 707 N GLY A 657 SHEET 4 AA2 4 THR A 693 VAL A 701 -1 N THR A 697 O ASP A 710 LINK OE2 GLU A 430 CA CA A 802 1555 1555 2.38 LINK NE2 HIS A 455 ZN ZN A 801 1555 1555 2.07 LINK NE2 HIS A 459 ZN ZN A 801 1555 1555 1.97 LINK O GLY A 463 CA CA A 802 1555 1555 2.42 LINK O VAL A 467 CA CA A 802 1555 1555 2.32 LINK O GLY A 469 CA CA A 802 1555 1555 2.26 LINK OE1 GLU A 487 ZN ZN A 801 1555 1555 2.06 LINK ZN ZN A 801 S03 T8E A 803 1555 1555 2.30 LINK CA CA A 802 O HOH A 989 1555 1555 2.40 LINK CA CA A 802 O HOH A1006 1555 1555 2.53 CRYST1 51.425 81.981 102.954 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019446 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012198 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009713 0.00000